INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.72B / 19S · 11 late91 trades$22.97M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10CMCannon-Brookes Michael35B / 0S35 trades$11.72M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,187 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CT
Cabot Jeffrey TChief Accounting Officer
STEMSTEM, INC.
Grant or award
A—
3,500 sh
Jan 5, 2026Jan 7, 2026
Page 1568 of 1855
← PrevNext →
traded Jan 5, 2026
+2d
SEC Form 4

Evidence

9
CC
Canale-Theakston CarinDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
16.0K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
BD
Black DondiDirector
IDNIntellicheck, Inc.
Grant or award
A—
785 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
CC
Canale-Theakston CarinDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
875 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
MJ
Merson JamesDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
2,125 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
HE
Hall Justin EEVP
NDSNNORDSON CORP
Tax withholding
F$15K
63 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
EL
Engstrom Jamie LDirector
AEEAMEREN CORP
Grant or award
A—
1,686 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
SM
Sems Richard MChief Executive Officer, Bank
EQBKEQUITY BANCSHARES INC
Grant or award
A—
61.9K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
CC
Clark George C.VP, Chief Accounting Officer
BHVNBiohaven Ltd.
Option exercise
M—
2,500 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
LK
Lefferts KellyEVP, Chief Legal Officer
BLMNBloomin' Brands, Inc.
Grant or award
A—
46.3K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
WG
Watkinson David GeorgeDirector, CEO and President
RYESRise Gold Corp.
Disposition to issuer
D—
250.0K sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

9
TE
Taylor Timothy EvanDirector, VP, Finance & Operations
GSATGlobalstar, Inc.
Grant or award
A—
6,666 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
PJ
Pace Philip JSVP, Chief Accounting Officer
BLMNBloomin' Brands, Inc.
Grant or award
A—
23.1K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
MS
McGinnis Eric SPresident, Climate Solutions
MODMODINE MANUFACTURING CO
Option exercise
M—
2,071 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
BG
Braca GregoryDirector
IDNIntellicheck, Inc.
Grant or award
A—
3,925 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
DN
Davarpanah Nicole NegarChief Medical Officer
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
5,000 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
MM
Merchant ManishaEVP / Chief Legal Officer
BCALCalifornia BanCorp \ CA
Tax withholding
F$23K
1,238 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

9
CC
Canale-Theakston CarinDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
2,125 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
AG
Auwaerter Paul GisbertDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
5,420 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
KM
Kelliher MikeDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
VC
Voinovich Michael CDirector
GBFHGBank Financial Holdings Inc.
Grant or award
A$10K
280 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

9
SS
Subramanian SrinivasExecutive Vice President
NDSNNORDSON CORP
Tax withholding
F$37K
149 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
SR
Spencer RyanDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
4,250 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
CT
Cabot Jeffrey TChief Accounting Officer
STEMSTEM, INC.
Grant or award
A—
3,500 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
YC
Yarkoni CharlotteDirector
TRUTransUnion
Grant or award
A—
836 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

8
PG
Patel Rahul G.Director, See remarks below
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$194K
2,282 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

7
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M—
29.3K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

5
BS
Beri SanjayDirector, CEO and Chairman
NTSKNetskope Inc
Derivative conversion
C—
31.6K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

5
BS
Beri SanjayDirector, CEO and Chairman
NTSKNetskope Inc
Derivative conversion
C—
31.6K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

5
HM
Hafner Patrick MEVP, Pres Outback Steakhouse
BLMNBloomin' Brands, Inc.
Grant or award
A—
115.7K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

5
TK
Truong KristinaChief Accounting Officer
ENVXEnovix Corp
Tax withholding
F$6,085
697 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

5
BS
Beri SanjayDirector, CEO and Chairman
NTSKNetskope Inc
Derivative conversion
C—
178.5K sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

5
SH
Sauer Richard HarryChief Legal Officer & Secty
WDAYWorkday, Inc.
Tax withholding · 10b5-1 plan
F$730K
3,549 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$779K
45.0K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

4
DS
Desmond SeanDirector, CEO & President
NCNOnCino, Inc.
Open-market sale · 10b5-1 plan
SELL$180K
7,331 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

4
FR
Fukushima RyanChief Operating Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$321K
5,000 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

3
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Option exercise · 10b5-1 plan
M—
3,808 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

2
HK
Holleran KevinDirector, President and CEO
HAYWHayward Holdings, Inc.
Option exercise · 10b5-1 plan
M$73K
52.4K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

1
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$53K
2,500 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence